IFP Advisors, Inc - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$2,602
-69.6%
73
-50.0%
0.00%
Q2 2023$8,546
+65.0%
146
+100.0%
0.00%
Q1 2023$5,179
+32268.8%
73
-68.0%
0.00%
Q4 2022$16
-99.8%
228
+60.6%
0.00%
Q3 2022$10,0000.0%1420.0%0.00%
Q2 2022$10,0000.0%1420.0%0.00%
Q1 2022$10,000142
+3450.0%
0.00%
Q2 2021$0
-100.0%
4
-71.4%
0.00%
Q1 2021$2,000
-50.0%
14
-56.2%
0.00%
Q4 2020$4,000
+300.0%
32
+220.0%
0.00%
Q3 2020$1,000100.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2018$1,0000.0%140.0%0.00%
Q2 2018$1,00014
+250.0%
0.00%
Q3 2017$040.0%0.00%
Q2 2017$040.0%0.00%
Q1 2017$040.0%0.00%
Q4 2016$040.0%0.00%
Q3 2016$040.0%0.00%
Q2 2016$0
-100.0%
4
-63.6%
0.00%
Q4 2015$1,000110.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 497,899$31,617,0003.20%
HIGHLINE CAPITAL MANAGEMENT, L.P. 390,453$24,794,0001.81%
First Light Asset Management, LLC 180,017$11,431,0001.59%
Rock Springs Capital Management LP 580,000$36,830,0001.33%
Capital Impact Advisors, LLC 36,165$2,244,0000.82%
SECTOR GAMMA AS 79,653$5,058,0000.81%
Verity Asset Management, Inc. 7,193$457,0000.51%
Opus Point Partners Management, LLC 5,064$322,0000.48%
Capital International Sarl 52,000$3,302,0000.46%
PACIFIC VIEW ASSET MANAGEMENT, LLC 6,216$394,0000.43%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders